Skip to main content

Athletic Performance: Drugs and Ergogenic Aids

  • Chapter
  • First Online:
Modern Sports Dentistry

Part of the book series: Textbooks in Contemporary Dentistry ((TECD))

Abstract

Knowledge of all drugs being prescribed for athletes on a team is very important for all members of the sports medicine team. Treatment of medical conditions, infections, pain, and trauma may require use of prescription medications. Many of these medications carry risk of side effects and interactions with other drugs as well as possible risk of dependency. It is important for the sports dentist to realize all of the risks and side effects of drugs prescribed as well as who else on the sports medicine team is a potential prescriber. Athletes may also get medications from friends and team mates or from the street to self- treat their conditions. Athletes also may seek out performance-enhancing drugs (PEDs) to assist them in achieving optimum performance in this highly competitive environment. This chapter will help the team dentist to be knowledgeable in these matters.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Alaranta A, Alaranta H, et al. Use of prescription drugs in athletes. Sports Med. 2008;38:449–63.

    Article  Google Scholar 

  2. Burstein R, Hourvitz A, Epstein Y, Dvir Z, Moran D, Altar J, Shemer J, Shalev A, Galun E. The relationship between short-term antibiotic treatments and fatigue in healthy individuals. Eur J Appl Physiol Occup Physiol. 1993;66(4):372–5.

    Article  Google Scholar 

  3. Schmid-Wendtner MH, Korting HC. Penciclovir cream—improved topical treatment for herpes simplex infections. Skin Pharmacol Physiol. 2004;17(5):214–8.

    Article  Google Scholar 

  4. Tubridy E, Kelsberg G, et al. Which drugs are most effective for recurrent herpes labialis? J Fam Pract. 2014;63(2):104–5.

    PubMed  Google Scholar 

  5. Opstelten W, Knuistingh A, et al. Treatment and prevention of herpes labialis. Can Fam Physician. 2008;54:1683–7.

    PubMed  PubMed Central  Google Scholar 

  6. Lee J, Kim JK, et al. Recovery time of platelet function after aspirin withdrawal. Curr Ther Res Clin Exp. 2014;76:26–31.

    Article  Google Scholar 

  7. Cahill RA, McGreal GT, et al. Duration of increased bleeding tendency after cessation of aspirin therapy. J Am Coll Surg. 2005;200(4):564–73.

    Article  Google Scholar 

  8. Cea Soriano L, Soriano-Gabarró M, García Rodríguez LA. Validation of low-dose aspirin prescription data in The Health Improvement Network: how much misclassification due to over-the-counter use? Pharmacoepidemiol Drug Saf. 2015. https://doi.org/10.1002/pds.3926. [Epub ahead of print].

  9. Anderson K, Hamm RL. Review article: Factors that impair wound healing. J Am Coll Clin Wound Spec. 2014;4(4):84–91.

    Article  Google Scholar 

  10. Bailey S, Patrick O’Connor J. NSAID therapy effects on healing of bone, tendon, and the enthesis. J Appl Physiol. 2013;115(6):892–9. https://doi.org/10.1152/japplphysiol.00053.2013. Epub 2013 Jul 18.

    Article  Google Scholar 

  11. Patrignani P, Tacconelli S, Bruno A, Sostres C, Lanas A. Managing the adverse effects of nonsteroidal anti- inflammatory drugs. Expert Rev Clin Pharmacol. 2011;4(5):605–21.

    Article  Google Scholar 

  12. Moore PA, Hersh EV. Combining ibuprofen and acetaminophen for acute pain management after third-molar extractions: translating clinical research to dental practice. J Am Dent Assoc. 2013;144(8):898–908.

    Article  Google Scholar 

  13. Menhinick KA, Gutmann JL, et al. The efficacy of pain control following nonsurgical root canal treatment using ibuprofen or a combination of ibuprofen and acetaminophen in a randomized, double-blind, placebo-controlled study. Int Endod J. 2004;37(8):531–41.

    Article  Google Scholar 

  14. Mehlisch DR, Aspley S, et al. Comparison of the analgesic efficacy of concurrent ibuprofen and paracetamol with ibuprofen or paracetamol alone in the management of moderate to severe acute postoperative dental pain in adolescents and adults: a randomized, double-blind, placebo-controlled, parallel- group, single-dose, two-center, modified factorial study. Clin Ther. 2010;32(5):882–95.

    Article  Google Scholar 

  15. Mehlisch DR, Aspley S, et al. A single-tablet fixed-dose combination of racemic ibuprofen/paracetamol in the management of moderate to severe postoperative dental pain in adult and adolescent patients: a multicenter, two-stage, randomized, double- blind, parallel-group, placebo-controlled, factorial study. Clin Ther. 2010;32(6):1033–49.

    Article  Google Scholar 

  16. Cottler LB, Ben Abdallah A, et al. Injury, pain, and prescription opioid use among former National Football League (NFL) players. Drug Alcohol Depend. 2011;116(1-3):188–94.

    Article  Google Scholar 

  17. McCabe SE, West BT, et al. Motives for medical misuse of prescription opioids among adolescents. J Pain. 2013;14(10):1208–16. https://doi.org/10.1016/j.jpain.2013.05.004. Epub 2013 Aug 15.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Pennsylvania guidelines on the use of opioids in dental practice. July 2015. proper reference format.

    Google Scholar 

  19. Denisco RC, Kenna GA, et al. Prevention of prescription opioid abuse: the role of the dentist. J Am Dent Assoc. 2011;142(7):800–10.

    Article  Google Scholar 

  20. Diehl K, Thiel A, et al. Substance use among elite adolescent athletes: findings from the GOAL Study. Scand J Med Sci Sports. 2014;24:250–8.

    Article  Google Scholar 

  21. Petróczi A, Aidman E. Psychological drivers in doping: the life-cycle model of performance enhancement. Subst Abuse Treat Prev Policy. 2008;3:7.

    Article  Google Scholar 

  22. Terry-McElrath YM, O’Malley P, et al. Middle and high school drug testing and student illicit drug use: a national study 1998-2011. J Adolesc Health. 2013;52(6):707–15.

    Article  Google Scholar 

  23. Castillo EM, Dawn Comstock R. Performance enhancing drugs prevalence of use of performance-enhancing substances among United States adolescents. Pediatr Clin. 2007;54(4):663–75.

    Article  Google Scholar 

  24. Thevis M, Kuuranne T, et al. Annual banned-substance review: analytical approaches in human sports drug testing. Drug Test Anal. 2016;8(1):7–29.

    Article  Google Scholar 

  25. Momaya A, Fawal M, et al. Performance-enhancing substances in sports: a review of the literature. Sports Med. 2015;45(4):517–31.

    Article  Google Scholar 

  26. Handelsman DJ. Performance enhancing hormone doping in sport. In: De Groot LJ, Beck-Peccoz P, Chrousos G, Dungan K, Grossman A, Hershman JM, Koch C, McLachlan R, New M, Rebar R, Singer F, Vinik A, Weickert MO, editors. 2015. Source: Endotext. South Dartmouth: MDText.com; 2000.

    Google Scholar 

  27. Parkinson AB, Evans NA. Anabolic androgenic steroids: a survey of 500 users. Med Sci Sports Exerc. 2006;38(4):644–51.

    Article  Google Scholar 

  28. Sagoe D, Andreassen CS, et al. The aetiology and trajectory of anabolic-androgenic steroid use initiation: a systematic review and synthesis of qualitative research. Subst Abuse Treat Prev Policy. 2014;9:27.

    Article  Google Scholar 

  29. DrugFacts: anabolic steroids. Rev July 2012. National Institute on Drug Abuse; National Institutes of Health; U.S. Department of Health and Human Services. http://www.steroidabuse.gov/.

  30. Sci American. 2004;291(1).

    Google Scholar 

  31. Reardon CL, Creado S. Drug abuse in athletes. Subst Abuse Rehabil. 2014;(5):95–105.

    Google Scholar 

  32. Tandon S, Bowers LD, et al. Treating the elite athlete: anti-doping information for the health professional. Mo Med. 2015;112(2):122–8.

    PubMed  Google Scholar 

  33. Kersey RD, Elliot DL. National Athletic Trainers’ Association position statement: anabolic-androgenic steroids. J Athl Train. 2012;47(5):567–88.

    Article  Google Scholar 

  34. Zinder SM, Basler RS. National Athletic Trainers’ Association position statement: skin diseases. J Athl Train. 2010;45(4):411–28.

    Article  Google Scholar 

Books

  • Glick M, editor. Burket’s oral medicine, 12th ed. Raleigh: Peoples Medical Publishing House; 2015.

    Google Scholar 

  • Malamed S. Handbook of local anesthesia. 6th ed. St. Louis: Elsevier Mosby; 2011.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Rye, L. (2018). Athletic Performance: Drugs and Ergogenic Aids. In: Roettger, M. (eds) Modern Sports Dentistry. Textbooks in Contemporary Dentistry. Springer, Cham. https://doi.org/10.1007/978-3-319-44416-1_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-44416-1_12

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-44414-7

  • Online ISBN: 978-3-319-44416-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics